Stoppa-Lyonnet D - Search Results

1

[Oncogenetic consultation for breast cancer].

Chompret A, Noguès C, Stoppa-Lyonnet D. Chompret A, et al. Presse Med. 2007 Feb;36(2 Pt 2):357-63. doi: 10.1016/j.lpm.2006.12.003. Epub 2007 Jan 9. Presse Med. 2007. PMID: 17258685 Review. French.

2

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.

Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Bénard J, Bressac-de Paillerets B. Soufir N, et al. Hum Mol Genet. 1998 Feb;7(2):209-16. doi: 10.1093/hmg/7.2.209. Hum Mol Genet. 1998. PMID: 9425228

3

[Genetic predispositions to breast cancer].

Stoppa-Lyonnet D. Stoppa-Lyonnet D. Presse Med. 1997 Dec 20;26(40):1978-80. Presse Med. 1997. PMID: 9537001 French.

4

Breast and ovarian cancer prone women and prophylactic surgery temptation.

Eisinger F, Julian-Reynier C, Stoppa-Lyonnet D, Vennin P, Lasset C, Noguès C, Sobol H. Eisinger F, et al. J Clin Oncol. 1998 Jul;16(7):2573-5. doi: 10.1200/JCO.1998.16.7.2573. J Clin Oncol. 1998. PMID: 9667284 No abstract available.

5

[Psychosocial impact of the first oncogenetic consultation in a familial context of cancers of the breast and the ovary].

Blandy C, Schwab S, Stoppa-Lyonnet D, Dazord A. Blandy C, et al. Bull Cancer. 1998 Jul;85(7):637-43. Bull Cancer. 1998. PMID: 9752272 Free article. French.

6

Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.

Essioux L, Girodet C, Sinilnikova O, Pagès S, Eisinger F, de Résende S, Maugard C, Lanoë D, Longy M, Bignon YJ, Sobol H, Bonaïti-Pellié C, Stoppa-Lyonnet D. Essioux L, et al. Am J Med Genet. 1998 Sep 23;79(3):175-83. doi: 10.1002/(sici)1096-8628(19980923)79:3<175::aid-ajmg5>3.0.co;2-m. Am J Med Genet. 1998. PMID: 9788557

7

[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].

Eisinger F, Alby N, Bremond A, Dauplat J, Espié M, Janiaud P, Kuttenn F, Lebrun JP, Lefranc JP, Pierret J, Sobol H, Stoppa-Lyonnet D, Thouvenin D, Tristant H, Feingold J. Eisinger F, et al. Ann Genet. 1999;42(1):51-64. Ann Genet. 1999. PMID: 10214508 French.

8

Genetic testing for breast cancer predisposition.

Gauthier-Villars M, Gad S, Caux V, Pagès S, Blandy C, Stoppa-Lyonnet D. Gauthier-Villars M, et al. Surg Clin North Am. 1999 Oct;79(5):1171-87, xxi. doi: 10.1016/s0039-6109(05)70067-0. Surg Clin North Am. 1999. PMID: 10572557 Review.

9

Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.

Sobol H, Bignon YJ, Bonaiti C, Cuisenier J, Lasset C, Lortholary A, Noguès C, Stoppa-Lyonnet D, Eisinger F. Sobol H, et al. Dis Markers. 1999 Oct;15(1-3):15-29. doi: 10.1155/1999/140498. Dis Markers. 1999. PMID: 10595246 Free PMC article.

10

Acceptability of prophylactic mastectomy in cancer-prone women.

Eisinger F, Julian-Reynier C, Sobol H, Stoppa-Lyonnet D, Lasset C, Nogues C. Eisinger F, et al. JAMA. 2000 Jan 12;283(2):202-3. doi: 10.1001/jama.283.2.202. JAMA. 2000. PMID: 10634335 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters